Abiopharma

🔍 Gajendra Sanjay (Director)

Company: Astera Labs, Inc. (ALAB)

Report Date: 2026-05-07

Detailed Transactions and Holdings:

• Sold 4,725 shares of Common Stock at $193.0138 per share (Direct)
  Date: 2026-05-07 | Code: S | equity_swap_involved: 0 | shares_owned_after: 5,859,488.00 | transaction_form_type: 4 | Footnotes: F1, F2, F3
• Sold 11,436 shares of Common Stock at $193.9541 per share (Direct)
  Date: 2026-05-07 | Code: S | equity_swap_involved: 0 | shares_owned_after: 5,848,052.00 | transaction_form_type: 4 | Footnotes: F1, F4, F3
• Sold 15,523 shares of Common Stock at $194.9112 per share (Direct)
  Date: 2026-05-07 | Code: S | equity_swap_involved: 0 | shares_owned_after: 5,832,529.00 | transaction_form_type: 4 | Footnotes: F1, F5, F3
• Sold 28,387 shares of Common Stock at $195.7393 per share (Direct)
  Date: 2026-05-07 | Code: S | equity_swap_involved: 0 | shares_owned_after: 5,804,142.00 | transaction_form_type: 4 | Footnotes: F1, F6, F3
• Sold 4,568 shares of Common Stock at $196.9382 per share (Direct)
  Date: 2026-05-07 | Code: S | equity_swap_involved: 0 | shares_owned_after: 5,799,574.00 | transaction_form_type: 4 | Footnotes: F1, F7, F3
• Sold 45,536 shares of Common Stock at $198.2063 per share (Direct)
  Date: 2026-05-07 | Code: S | equity_swap_involved: 0 | shares_owned_after: 5,754,038.00 | transaction_form_type: 4 | Footnotes: F1, F8, F3
• Sold 43,016 shares of Common Stock at $198.8236 per share (Direct)
  Date: 2026-05-07 | Code: S | equity_swap_involved: 0 | shares_owned_after: 5,711,022.00 | transaction_form_type: 4 | Footnotes: F1, F9, F3
• Sold 10,913 shares of Common Stock at $199.8988 per share (Direct)
  Date: 2026-05-07 | Code: S | equity_swap_involved: 0 | shares_owned_after: 5,700,109.00 | transaction_form_type: 4 | Footnotes: F1, F10, F3
• Sold 9,016 shares of Common Stock at $200.8613 per share (Direct)
  Date: 2026-05-07 | Code: S | equity_swap_involved: 0 | shares_owned_after: 5,691,093.00 | transaction_form_type: 4 | Footnotes: F1, F11, F3
• Sold 8,477 shares of Common Stock at $202.0899 per share (Direct)
  Date: 2026-05-07 | Code: S | equity_swap_involved: 0 | shares_owned_after: 5,682,616.00 | transaction_form_type: 4 | Footnotes: F1, F12, F3
• Sold 8,208 shares of Common Stock at $202.8939 per share (Direct)
  Date: 2026-05-07 | Code: S | equity_swap_involved: 0 | shares_owned_after: 5,674,408.00 | transaction_form_type: 4 | Footnotes: F1, F13, F3
• Sold 2,702 shares of Common Stock at $203.8931 per share (Direct)
  Date: 2026-05-07 | Code: S | equity_swap_involved: 0 | shares_owned_after: 5,671,706.00 | transaction_form_type: 4 | Footnotes: F1, F14, F3
• Sold 2,915 shares of Common Stock at $205.2626 per share (Direct)
  Date: 2026-05-07 | Code: S | equity_swap_involved: 0 | shares_owned_after: 5,668,791.00 | transaction_form_type: 4 | Footnotes: F1, F15, F3
• Sold 1,163 shares of Common Stock at $205.9391 per share (Direct)
  Date: 2026-05-07 | Code: S | equity_swap_involved: 0 | shares_owned_after: 5,667,628.00 | transaction_form_type: 4 | Footnotes: F1, F16, F3
• Sold 3,415 shares of Common Stock at $213.49 per share (Direct)
  Date: 2026-05-07 | Code: S | equity_swap_involved: 0 | shares_owned_after: 5,664,213.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Sold 945 shares of Common Stock at $193.0137 per share (Direct)
  Date: 2026-05-07 | Code: S | equity_swap_involved: 0 | shares_owned_after: 694,055.00 | transaction_form_type: 4 | Footnotes: F1, F2, F17
• Sold 2,288 shares of Common Stock at $193.9542 per share (Direct)
  Date: 2026-05-07 | Code: S | equity_swap_involved: 0 | shares_owned_after: 691,767.00 | transaction_form_type: 4 | Footnotes: F1, F4, F17
• Sold 3,104 shares of Common Stock at $194.9113 per share (Direct)
  Date: 2026-05-07 | Code: S | equity_swap_involved: 0 | shares_owned_after: 688,663.00 | transaction_form_type: 4 | Footnotes: F1, F5, F17
• Sold 5,677 shares of Common Stock at $195.7392 per share (Direct)
  Date: 2026-05-07 | Code: S | equity_swap_involved: 0 | shares_owned_after: 682,986.00 | transaction_form_type: 4 | Footnotes: F1, F18, F17
• Sold 914 shares of Common Stock at $196.938 per share (Direct)
  Date: 2026-05-07 | Code: S | equity_swap_involved: 0 | shares_owned_after: 682,072.00 | transaction_form_type: 4 | Footnotes: F1, F7, F17
• Sold 9,108 shares of Common Stock at $198.2063 per share (Direct)
  Date: 2026-05-07 | Code: S | equity_swap_involved: 0 | shares_owned_after: 672,964.00 | transaction_form_type: 4 | Footnotes: F1, F8, F17
• Sold 8,603 shares of Common Stock at $198.8237 per share (Direct)
  Date: 2026-05-07 | Code: S | equity_swap_involved: 0 | shares_owned_after: 664,361.00 | transaction_form_type: 4 | Footnotes: F1, F9, F17

Footnotes:

• F1: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2025.
• F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $192.4400 to $193.4300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F3: These shares are owned directly by an estate planning trust ("Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
• F4: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $193.4500 to $194.4400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F5: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $194.4500 to $195.4400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F6: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $195.4500 to $196.4100, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F7: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $196.4500 to $197.4400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F8: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $197.4500 to $198.4400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F9: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $198.4500 to $199.4300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F10: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $199.4500 to $200.4300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F11: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $200.4500 to $201.4400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F12: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $201.4600 to $202.4300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F13: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $202.5000 to $203.4700, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F14: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $203.5000 to $204.4200, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F15: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $204.5000 to $205.4000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F16: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $205.5000 to $206.0000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F17: These shares are owned directly by an estate planning trust ("Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
• F18: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $195.4500 to $196.4000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• REMARKS: This Form 4 is being filed in two parts due to the limitations of the U.S. Securities and Exchange Commission EDGAR filing system. Part 1 of 2.